The Traditional Approach
For decades, myelomeningocele — a neural tube defect where "the spinal cord does not close and is exposed on surface through an opening in the spine" 0:20 — was managed exclusively after birth 0:25. The rationale was straightforward: repair the defect once the infant was stable, the anatomy was fully visible, and the surgical field was accessible through standard neurosurgical technique. Postnatal closure carried known risks, but it was a problem that could be addressed with established methods in a controlled environment.
The limitation was biological rather than technical 0:25. The exposed neural placode continues to sustain damage throughout gestation from amniotic fluid exposure and mechanical trauma 0:25. By the time of delivery, secondary injury has already occurred — injury that postnatal repair cannot reverse 0:25.
What Changed
The shift began with the recognition that myelomeningocele is a progressive condition in utero, not a static malformation 0:25. If the defect could be closed before ongoing damage accumulated, outcomes might improve 0:25. The question was whether fetal surgery could be performed safely enough to justify the maternal and obstetric risks.
Prenatal diagnosis became routine as ultrasound technology improved, making myelomeningocele detectable early in the second trimester 0:39. This created a window for intervention 0:39. Open fetal surgery — hysterotomy with direct repair — demonstrated that in utero closure was technically feasible, but it carried substantial maternal morbidity and risk of preterm delivery.
Fetoscopic technique offered a less invasive alternative 0:47. Rather than opening the uterus, surgeons could access the fetus through small ports, performing the repair endoscopically 0:47. The pregnant patient is placed under general anesthesia and the uterus is approached by midline laparotomy 0:47, but the uterus itself remains intact. After ultrasound mapping to avoid the placenta and major vessels 0:55, trocars are placed through the uterine wall 1:00, the amniotic fluid is partially removed, and the uterus is insufflated with carbon dioxide 1:14 to create a working space.
The fetal repair itself mirrors postnatal technique in principle but demands adaptation to the constraints of the fetoscopic field 1:35. The spinal cord is "circumferentially released, taking care not to injure the ascending spinal cord, lateral dorsal roots, or segmental vasculature" 1:41. The neural placode is reconstructed with interrupted 6-0 sutures 1:59. Dural closure uses running non-absorbable 6-0 suture 2:24 that "will persist long term and act as a useful guide if subsequent untethering is required" 2:24 — an acknowledgment that this repair may not be the last intervention. Skin closure follows in the mid-sagittal plane when possible 2:37, with blunt dissection to preserve vascular supply 2:49. When primary closure cannot be achieved, a synthetic skin graft is sutured to the defect edges to promote epithelialization 3:00.
Current Practice
Fetoscopic myelomeningocele repair is now performed at specialized centers, though it remains a high-complexity intervention 0:39. The incidence of neural tube defects in the United States is approximately 0.2 per 1000 live births 0:33, and "when diagnosed prenatally, these can be repaired during the fetal stage of life while in utero" 0:39. The procedure requires multidisciplinary coordination — maternal-fetal medicine, pediatric neurosurgery, anesthesia capable of managing both mother and fetus — and careful patient selection 0:39.
The fetus receives sedation with rocuronium, fentanyl, and atropine 1:26 before the repair begins. After closure, amniotic fluid is replaced with warmed lactated Ringer solution 3:12, the ports are removed, and the uterus and abdominal incision are closed 3:19. The pregnancy continues with close monitoring 3:19.
What Remains Unsettled
The long-term neurological outcomes of fetoscopic versus open fetal versus postnatal repair are still being defined. Early data suggest benefit, but the magnitude of that benefit, the durability of the repair, and the rate of subsequent tethering requiring reoperation are questions that require years of follow-up to answer.
Maternal risk remains a consideration. Any fetal intervention carries obstetric consequences — preterm labor, membrane complications, the need for cesarean delivery. The threshold for offering surgery depends on balancing fetal benefit against maternal burden, and that calculus is not uniform across cases.
Patient selection criteria are evolving. Not every myelomeningocele is a candidate for fetal repair. Lesion level, associated anomalies, gestational age at diagnosis, and maternal factors all influence whether intervention is appropriate. The field is still learning which patients benefit most and which are better served by postnatal management.
Finally, access is limited. Fetoscopic myelomeningocele repair requires infrastructure and expertise that few centers possess. Whether this will remain a highly centralized procedure or diffuse more broadly as technique matures is an open question.
Takeaways from this story
- Myelomeningocele can now be repaired in utero via fetoscopic technique to prevent ongoing neural damage during gestation.
- Fetoscopic repair uses trocar access and CO2 insufflation rather than hysterotomy, reducing maternal morbidity.
- Non-absorbable suture for dural closure persists long-term and guides potential future untethering procedures.
- Skin mobilization requires preserving subcutaneous fat layer to maintain vascular supply; synthetic grafts are used when primary closure fails.